Clinical Trial Update: Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy and safety of JMT103 for glucocorticoid-induced osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis

Drugs mentioned

• JMT103

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Glucocorticoid Induced Osteoporosis | Phase 2 | Status: UNKNOWN